Yaz for PMDD: does it work?

Yaz (drospirenone 3 mg with ethinylestradiol 20 mcg) is approved in the US for PMDD, but the clinical trial evidence is thinner than the approval suggests. The one placebo-controlled trial designed specifically for PMDD found women on Yaz improved more than those on placebo, but the gap wasn't statistically significant [2].

A separate Cochrane review of drospirenone pills for premenstrual syndrome found modest benefit for mood and physical symptoms, though most of the underlying trials were small and short, which limited the overall evidence quality [4].

For some people, Yaz still helps a lot. For others, the change may be close to what a placebo pill gives them. PMDD is a diagnosis in DSM-5-TR, and treatment response varies by person the way it does for most psychiatric medications.

The main PMDD-specific trial randomized 187 women to Yaz or placebo for three treatment cycles after a run-in period, using daily symptom ratings (DRSP) and clinician-rated severity (CGI) [2]. Both groups improved, which is typical in premenstrual trials: tracking symptoms daily and taking any pill often helps on its own.

The Yaz group's median DRSP score dropped further than the placebo group's, but the difference didn't reach statistical significance [2].

A 2012 Cochrane review pooled several drospirenone trials across PMS and PMDD. It found some improvement in premenstrual symptoms, strongest when drospirenone was combined with a low-dose estrogen and taken continuously, but the authors rated the overall evidence as low to moderate quality because trials were short and inconsistently designed [4].

One trial tested whether adding an SSRI helped more than a drospirenone pill alone for severe PMS: combining fluoxetine with the pill improved symptoms in 65% of women by the sixth cycle, compared with 50% on the pill alone [3]. That's a clue that for some people, the pill alone may not be enough.

Yaz is taken as a 24/4 pack: 24 active pills containing drospirenone and ethinylestradiol, followed by 4 inactive pills, repeated every 28 days [2]. That shorter pill-free interval, compared with the older 21/7 pattern, is meant to shorten the hormone-free window when premenstrual symptoms can resurface.

Some women take it continuously, skipping the inactive pills and starting a new pack right away, to avoid a symptomatic gap altogether. That's a decision for a doctor, based on bleeding pattern and the goal, whether that's contraception, symptom control, or both.

A doctor sets the specific plan: how long to try it before judging effect, whether to adjust the pill-free interval, and what to do if breakthrough bleeding shows up in the first cycles. For a fuller rundown of dosing, see Yaz dosage.

In the main PMDD trial, women were followed for three full treatment cycles before researchers compared Yaz to placebo [2]. That's a reasonable timeline to expect: premenstrual symptoms are tied to a hormonal pattern that plays out across months, and one or two cycles often isn't enough to tell a real difference from normal month-to-month variation.

Breakthrough bleeding and other early side effects tend to settle by the third cycle for most people, which is part of why that timepoint shows up in trials.

If nothing has shifted by three months, that's useful information for the next conversation with a doctor, not a sign to tough it out indefinitely. More on timing at how long does Yaz take to work.

In the PMDD trial, side effects on Yaz were more common than on placebo [2]:

• Breakthrough bleeding: 13% versus 3% on placebo
• Heavier periods (menorrhagia): 9% versus 1%
• Nausea: 5% versus 4%
• Skin rash: 4% versus 2%

Most of these cluster in the first few cycles and ease as the body adjusts.

A separate trial comparing drospirenone pills with another combined pill found drospirenone users reported less water retention and better general well-being during their period, which lines up with how drospirenone works: it has a mild diuretic effect that can offset the bloating some people get from estrogen [1].

Drospirenone also raises potassium slightly, which matters for anyone on medications that do the same. For the fuller list, including rarer but more serious risks like blood clots, see Yaz side effects.

Yaz is a combined hormonal contraceptive, so the usual contraindications for estrogen-containing pills apply: a history of blood clots, certain migraines with aura, uncontrolled high blood pressure, smoking over age 35, or a history of hormone-sensitive cancers.

Because drospirenone raises potassium slightly, it's used cautiously alongside kidney disease, adrenal insufficiency, or other medications that raise potassium, such as some blood pressure drugs.

A doctor reviews your personal and family history before prescribing any combined pill, PMDD or not. If you're weighing Yaz specifically against other options, birth control for PMDD covers how it compares with other hormonal approaches.

Yaz doesn't have to be the only tool. An 8-week internet-based CBT program for PMDD improved functional impairment and symptom intensity compared with a waitlist, with effects holding steady at six months [5].

Combining an SSRI with a drospirenone pill outperformed the pill alone for severe premenstrual symptoms in one trial, so if Yaz alone isn't enough, that's a reasonable next question for a doctor rather than a sign to stop [3].

In the moment, naming what's happening before it escalates often helps more than waiting for a pill to kick in. Niyora is a PMS and PMDD support app. Its Moon feature lets you write down what happened in a fight, look at it from another angle once the wave passes, and draft a reply you can hold for 20 minutes instead of sending something in the heat of it.

See PMDD treatment for how SSRIs, hormonal options, and therapy fit together.